KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,355,415 | -47.8% | 43,500 | -33.1% | 0.96% | -31.6% |
| Q2 2023 | $14,095,250 | +83.6% | 65,000 | +53.8% | 1.41% | +24.4% |
| Q1 2023 | $7,678,831 | -20.4% | 42,275 | -13.9% | 1.13% | -18.2% |
| Q4 2022 | $9,644,417 | -52.9% | 49,081 | -46.1% | 1.39% | -20.1% |
| Q3 2022 | $20,469,000 | +205.3% | 91,000 | +71.7% | 1.74% | +130.2% |
| Q2 2022 | $6,705,000 | -26.6% | 53,000 | -26.4% | 0.75% | -2.0% |
| Q1 2022 | $9,129,000 | -7.1% | 72,000 | -4.0% | 0.77% | +11.6% |
| Q4 2021 | $9,825,000 | +642.6% | 75,000 | +581.8% | 0.69% | +499.1% |
| Q1 2021 | $1,323,000 | -79.7% | 11,000 | -82.8% | 0.12% | -77.4% |
| Q4 2020 | $6,502,000 | +14.4% | 64,000 | -12.9% | 0.51% | +9.5% |
| Q3 2020 | $5,683,000 | -32.0% | 73,500 | -2.0% | 0.46% | -56.9% |
| Q2 2020 | $8,359,000 | +29.0% | 75,000 | -16.7% | 1.08% | -13.0% |
| Q1 2020 | $6,480,000 | +17.8% | 90,000 | +23.3% | 1.24% | +16.9% |
| Q4 2019 | $5,500,000 | – | 73,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |